期刊文献+

成人肝癌组织褪黑素受体的表达和结合特性 被引量:5

The expression and binding property of melatonin receptor in adult hepatoma tissue
下载PDF
导出
摘要 目的检测成人肝癌组织是否表达褪黑素受体(me-latonin receptor,MR),并探讨其结合特性。方法免疫组化法检测肝癌组织MR两种亚型(MT1、MT2)的表达和分布。采用放射配体结合法检测肝癌组织MR特异性结合和动力学特性。结果免疫组化结果显示,成人肝癌组织MT1和MT2均呈聚集型粽黄色颗粒阳性染色,主要分布在细胞膜和细胞质,细胞核中表达最少。放射配体结合结果表明,成人肝癌组织存有125I标记的褪黑素(125I-Mel)特异结合位点,最大结合容量(Bmax)值为(0.29±0.07)pmol.g-1 protein,平衡解离常数(Kd)值为(48.7±6.5)pmol·L-1,动力学分析表明该特异性结合特点为可饱和及可逆性结合。结论成人肝癌组织表达MR,包括MT1和MT2,其结合特性为低结合容量、高亲和力、可饱和性及可逆性。 Aim To determine whether there existed melatonin receptor (MR) in adult hepatoma tissue and to observe its property of binding. Methods Immunohistochemistry was used to detect MR and identify its subcellular distribution. Specific binding and kinetic analyses of melatonin receptor were measured by radioligand binding assay. Results The results of immunohistochemistry showed that MT1 and MT2 existed in membrane, cytosol and nucleus of the hepatoma cells, but the expression of them principally localized in the membrane and cytosol. The specific binding assay properties of MR were presented as follows: the maximum binding capacity ( Bmax ) was ( 0. 29 _+ 0. 07 ) pmol · g^-1 protein. Equilibrium dissociation constant ( Kd) was (48.7 _+ 6. 5) pmol · L^-1. The trait of MR, saturation and reversibility, was detected by ^125I-Mel specific binding kinetic analyses. Conclusions MR exists in adult hepatoma cells, furthermore, the subtypes of MR (MT1 and MT2) coexist in the membrane and cytosol, respectively, whose characters of the specific binding sites were low binding capacity, high affinity, saturation and reversibility.
出处 《中国药理学通报》 CAS CSCD 北大核心 2010年第2期174-177,共4页 Chinese Pharmacological Bulletin
基金 国家自然科学基金资助项目(No30973543)
关键词 成人 肝癌 褪黑素 褪黑素受体 褪黑素受体1 褪黑素受体2 adult hepatoma melatonin melatonin receptor melatonin receptorl melatonin receptor2
  • 相关文献

参考文献14

二级参考文献38

共引文献70

同被引文献27

  • 1李岚,徐尔理,张征,魏巍,刘志民.褪黑素与褪黑素受体在成人甲状腺肿瘤中的表达及其意义[J].临床肿瘤学杂志,2007,12(11):843-846. 被引量:3
  • 2Arika SK, Kasap B, Pintor J, et al. Impact of prognostic factors on survival rates in patients with ovarian carci-no- ma[J]. Asian Pae J Cancer Prev, 2014(15): 6087 - 6094.
  • 3Bretin-eiftci J, Barre B, Wiechmann AF, et al. pRb / E2F-l-mediated caspase-dependent induction of Noxa am- plifies the apoptotie effects of the Bcl-2/Bcl-xL inhibitor ABT - 737 [ J ]. Cell Death Differ, 2013 (5) :755 - 764.
  • 4Gencer S, Cebeci A, Rada JA, et al. Silencing of the MMP-3 gene by siRNA transfection in gastric cancer AGS cells [ J]. J Gastrointestin Liver Dis, 2011 ( 1 ) : 19 - 26.
  • 5Poudel S, Song J, Jin EJ, et al. Sulfuretin induced miR- 30C selectively downregulates cyelin D1 and D2 and trig- gers cell death in human cancer cell lines [ J ]. Biochem Biophys Res Com-mun, 2013(3) : 572 -578.
  • 6Tallant C, Marrero A, Comai S, et al. Cell cycle depend- ent acetylation of Rb2/pl30 in NIH3T3 cells [J]. Onco- gene, 2010(42) : 5755 -5760.
  • 7Helmbold H, Galderisi U, Dubocovich M L, et al. The switch from pRb/pl05 to Rb2/pl30 in DNA damage and cellular senescence [ J]. J Cell Physiol, 2012 (2): 508 -513.
  • 8李岚,何金,刘志民,张军初,等.成人甲状腺肿瘤褪黑素及褪黑素受体蛋白表达异常及意义[J].医学与哲学:临床决策论坛版,2011(5):57-59.
  • 9Yuan L , Collins A , Kiefer TL et al. Overexpression of the MT1 melatonin receptor in MCF-7 human breast canc- er ceils inhibits mammary tumor formation in nude mice [J]. Cailcer Lett, 2003(1) :49 -57.
  • 10Wang X, Sirianni A, Schernhammer ES, et al. A ran- domized controlled trial of oral melatonin supplementation and breast cancer biomarkers [ J] Cancer Cause Control, 2012(4): 609 - 616.

引证文献5

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部